TagsABT301

Tag: ABT301

Healthcare

AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer

Ravindra Soni - April 13, 2026 0

Healthcare

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

Ravindra Soni - August 4, 2025 0

Most Read

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

TukTuki streams ‘What Is Dyslexia’ film for Dyslexia Awareness Month

November 4, 2026

EDITOR PICKS

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

POPULAR POSTS

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.